Personalised Treatment for Breast Cancer Patients

 

 

As part of ESMO's continuous commitment to offering beneficial educational material relevant to your work and practice in order to receive your certificate, please complete the Evaluation Survey, which will take approximately 5 minutes. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did participation at this E-Learning module allow you to assess the strengths and weaknesses of the main techniques used for the prediction of clinical outcome in breast cancer? (1-not at all; 5-a lot)

2. Did participation at this E-Learning module allow you to evaluate the tests that can predict the efficacy of specific drugs used in the treatment of breast cancer? (1-not at all; 5-a lot)

3. Did this E-Learning module provide a future direction/strategy for the management of breast cancer patients who are at high risk for disease relapse? (1-not at all; 5-a lot)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in this E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-completely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestions to improve future ESMO E-Learning material, please write in the box below: